[go: up one dir, main page]

CO4600644A1 - Vacuna contra el sindrome reproductivo y respiratorio porcino - Google Patents

Vacuna contra el sindrome reproductivo y respiratorio porcino

Info

Publication number
CO4600644A1
CO4600644A1 CO97010338A CO97010338A CO4600644A1 CO 4600644 A1 CO4600644 A1 CO 4600644A1 CO 97010338 A CO97010338 A CO 97010338A CO 97010338 A CO97010338 A CO 97010338A CO 4600644 A1 CO4600644 A1 CO 4600644A1
Authority
CO
Colombia
Prior art keywords
vaccine
virus
attenuated
respiratory syndrome
live
Prior art date
Application number
CO97010338A
Other languages
English (en)
Spanish (es)
Inventor
Richard A Hesse
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24442410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4600644(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of CO4600644A1 publication Critical patent/CO4600644A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
CO97010338A 1996-03-01 1997-02-26 Vacuna contra el sindrome reproductivo y respiratorio porcino CO4600644A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60980696A 1996-03-01 1996-03-01

Publications (1)

Publication Number Publication Date
CO4600644A1 true CO4600644A1 (es) 1998-05-08

Family

ID=24442410

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97010338A CO4600644A1 (es) 1996-03-01 1997-02-26 Vacuna contra el sindrome reproductivo y respiratorio porcino

Country Status (19)

Country Link
EP (1) EP0894007A1 (fr)
JP (1) JP3135069B2 (fr)
KR (1) KR100297537B1 (fr)
CN (1) CN1165342C (fr)
AR (1) AR006023A1 (fr)
AU (1) AU2277497A (fr)
BG (1) BG64693B1 (fr)
BR (1) BR9708443B1 (fr)
CA (1) CA2248182C (fr)
CO (1) CO4600644A1 (fr)
CZ (1) CZ273798A3 (fr)
EE (1) EE04741B1 (fr)
HU (1) HUP9901958A3 (fr)
MY (1) MY115070A (fr)
PL (1) PL328627A1 (fr)
RU (1) RU2187333C2 (fr)
SK (1) SK119498A3 (fr)
WO (1) WO1997031651A1 (fr)
ZA (1) ZA971663B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0839912A1 (fr) 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Clones infectieux de virus à ARN, vaccins et essais diagnostiques
CA2440933A1 (fr) 1998-12-22 2000-06-22 Pfizer Products Inc. Un clone d'adnc infectieux du virus nord-americain du syndrome dysgenesique respiratoire porcin (sdrp) et ses utilisations
CA2366072C (fr) 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Vaccins contre le virus du syndrome dysgenesique respiratoire porcin (srdp)
EP1183332B1 (fr) 1999-04-22 2010-07-14 United States Department Of Agriculture Vaccin contre le syndrome dysgenesique respiratoire porcin base sur l'isolat ja-142
AU2005265142A1 (en) 2004-06-18 2006-01-26 Regents Of The University Of Minnesota Identifying virally infected and vaccinated organisms
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
HUE031018T2 (hu) 2005-06-24 2017-06-28 Univ Minnesota PRRS vírusok, fertõzõ klónok, ezek mutánsai és alkalmazási eljárások
RU2354333C1 (ru) * 2007-07-24 2009-05-10 ФГОУ ВПО Омский государственный аграрный университет Способ ранней диагностики послеродовых заболеваний у свиноматок
CN101612395B (zh) * 2008-06-24 2012-02-08 扬州优邦生物制药有限公司 一种培养敏感细胞生产蓝耳病疫苗的方法
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
MY186535A (en) 2011-02-17 2021-07-26 Boehringer Ingelheim Vetmedica Gmbh Novel european prrsv strain
SG192821A1 (en) 2011-02-17 2013-09-30 Boehringer Ingelheim Vetmed Commercial scale process for production of prrsv
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
EP2737058A1 (fr) 2011-07-29 2014-06-04 Boehringer Ingelheim Vetmedica GmbH Clone d'adnc infectieux du virus srrp européen et ses utilisations
KR101300528B1 (ko) * 2011-10-05 2013-09-02 캔 테크놀로지스 인코포레이티드 액티노바실러스 플루로뉴모니애 감염 방지 및 처치용 조성물
EP2968513A2 (fr) 2013-03-15 2016-01-20 Boehringer Ingelheim Vetmedica, Inc. Virus, compositions, vaccin et procédés d'utilisation du syndrome dysgénésique et respiratoire porcin
CZ309704B6 (cs) * 2020-12-10 2023-08-09 Univerzita Palackého v Olomouci Transportní médium pro transport a skladování virů
EP4012025A1 (fr) * 2020-12-10 2022-06-15 Univerzita Palackého v Olomouci Milieu de transport pour les échantillons contenant des acides nucléiques et/ou des protéines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6042830A (en) * 1992-08-05 2000-03-28 Boehringer Ingelheim Vetmedica, Inc. Viral agent associated with mystery swine disease
WO1993007898A1 (fr) * 1991-10-14 1993-04-29 Akzo Nobel N.V. Vaccin contre le syndrome respiratoire reproductif porcin
FR2686097B1 (fr) * 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
PL178609B1 (pl) * 1993-02-08 2000-05-31 Bayer Ag Izolat wirusa zespołu reprodukcyjnego i oddechowego świń zwanego PRRSV, sposób namnażania izolatu PRRSV, klon linii komórkowej, hodowla tkankowa zawierająca izolat PRRSV, szczepionka efektywna w ochronie świń przeciw PRRSV oraz sposób wytwarzania szczepionki efektywnej w ochronie świń przeciw PRRSV
ES2074950B1 (es) * 1993-09-17 1996-03-16 Iberica Cyanamid Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
ES2165405T3 (es) * 1994-04-11 2002-03-16 Akzo Nobel Nv Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv).
US5690940A (en) * 1995-06-21 1997-11-25 Regents Of The University Of Minnesota Low pathogencity PRRS live virus vaccines and methods of preparation thereof

Also Published As

Publication number Publication date
BG64693B1 (bg) 2005-12-30
CA2248182A1 (fr) 1997-09-04
RU2187333C2 (ru) 2002-08-20
MY115070A (en) 2003-03-31
SK119498A3 (en) 1999-07-12
HUP9901958A2 (hu) 1999-10-28
BG102809A (en) 1999-05-31
KR100297537B1 (ko) 2001-10-26
BR9708443A (pt) 1999-08-03
EE9800267A (et) 1999-02-15
KR19990087432A (ko) 1999-12-27
EE04741B1 (et) 2006-12-15
AR006023A1 (es) 1999-07-21
BR9708443B1 (pt) 2012-06-12
CZ273798A3 (cs) 1999-02-17
AU2277497A (en) 1997-09-16
HUP9901958A3 (en) 2000-04-28
PL328627A1 (en) 1999-02-15
JP3135069B2 (ja) 2001-02-13
CA2248182C (fr) 2004-04-20
WO1997031651A1 (fr) 1997-09-04
ZA971663B (en) 1997-08-26
CN1165342C (zh) 2004-09-08
JPH11506122A (ja) 1999-06-02
CN1216922A (zh) 1999-05-19
EP0894007A1 (fr) 1999-02-03
MX9807083A (es) 1998-12-31

Similar Documents

Publication Publication Date Title
CO4600644A1 (es) Vacuna contra el sindrome reproductivo y respiratorio porcino
CN101495138B (zh) 猪繁殖与呼吸综合征病毒（prrsv）的保护性抗原决定子的鉴定及其用途
ES2165405T3 (es) Cepas de vacuna europeas del virus del sindrome reproductor y respiratorio porcino (prrsv).
MXPA02011545A (es) Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
DE60024112D1 (de) Influenzavirus-impfstoffzusammensetzung
BRPI9911870B8 (pt) vacina de parvovírus e circovírus de suíno
ES2170234T3 (es) Vacuna contra el virus prrs (sindrome reproductor y respiratorio porcino).
WO2005021707A3 (fr) Compositions vaccinales d'adn contre le syndrome respiratoire aigu severe et leurs procedes d'utilisation
ES2118815T3 (es) Virus de la seudorrabia, s-prv-155, atenuado y obtenido por ingenieria genetica y sus usos.
AR057695A1 (es) Procedimientos de administracion de vacunas contra calcivirus felinos, y tratamientos para inmunizar animales contra parvovirus felino y herpes virus felino
NO20082472L (no) Vaksinesammensetninger omfattende en saponin adjuvant
CO4980846A1 (es) Una composicion farmaceutica utilizada en un metodo para la prevencion y tratamiento de la enfermedad amiloidogenica
ES2157522T3 (es) Cepas de vacunas europeas del virus del sindrome respiratorio reproductor porcino (prrsv).
RU2001101426A (ru) Аттенуированные вирусы с минус-цепью с измененной антагонистической в отношении интерферона активностью для применения в качестве вакцин и фармацевтических веществ
RU2010117614A (ru) Авирулентная адъювантная живая вакцина против mycoplasma hyopneumoniae
JP2002504317A5 (fr)
RU98118186A (ru) Вакцина против репродуктивного и респираторного синдрома у свиней
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
ATE516034T1 (de) Verfahren zur modulation der immunreaktion in einem infektierten säugetier mittels transmukosales eingeben eines modulationsmittel
ES2050435T3 (es) Una preparacion medicinal o vacuna y composicion inmunogenica peptida, un metodo de inmunizacion de un mamifero contra lhrh, y un metodo para mejorar la calidad carnica del ganado porcuno.
CO2021005066A2 (es) Vacuna de ibv 4/91 con proteína espicular heteróloga
AR116878A1 (es) Vacuna de ibv h52 con proteína espicular heteróloga
AR054259A1 (es) Vacuna contra virus de papiloma humano (hpv)